In the IGF-1 group , 66.7 % ( 95 % confidence interval [ CI ] , 52.9-78 .6 % ) of the patients showed hearing improvement compared to 53.6 % ( 95 % CI , 39.7-67 .0 % ) of the patients in the Dex group ( P = 0.109 ) .